NCI-H358 [H-358, H358] is an epithelial-like cell that was isolated from the bronchiole of a male patient with bronchioalveolar carcinoma. This cell line was deposited by AF Gazdar and JD …

Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Feasibility of drug screening with panels of human tumor cell lines using a …

Nov 29, 2021 · A tool SHP2 inhibitor compound developed by Revolution Medicine is RMC-4550, which showed significant in vivo results when targeting KRAS G12C H358 and MIAPaCa-2 …

Sep 5, 2024 · NCI-H358 is a human non-small cell lung cancer (NSCLC) cell line that is widely used in research related to KRAS gene mutations. The KRAS G12C mutation is relatively …

Oct 13, 2023 · We screened a panel of KRAS-G12C NSCLC cell lines and identified the ones that are inherently resistant or sensitive to sotorasib. We selected three cell lines, namely, H358, …

H358 is a non-small cell lung cancer (NSCLC) cell line that harbors a KRAS mutation. KRAS mutations are found in >25% of lung adenocarcinomas leading to constitutive activation of the …

High molecular weight genomic DNA isolated from the NCI-H358; human bronchioalveolar carcinoma; non-small cell lung cancer cell line.

Jan 5, 2022 · Cell information for NCI-H358. Find diseases associated with this biological target and compounds tested against it in bioassay experiments.

Cell Line: NCI-H358, Established from primary bronchioalveolar carcinoma of the lung from a Caucasian male

Dec 9, 2019 · NCI-H358 cancer cells with stably forced circFGFR1 expression were subcutaneously implanted into nude mice. Consistent with the above in vitro findings, the …